Last updated on July 2019

Evaluation of Quality of Life (QoL) in Subjects With Highly Active Relapsing Multiple Sclerosis (MS)


Brief description of study

The main purpose of the study is to assess the health-related quality of life (HRQoL) through the Multiple Sclerosis Quality of Life-54 Questionnaire (MSQoL-54) scale in highly-active relapsing multiple sclerosis (RMS) subjects treated with Mavenclad for 2 years (24 months).

Clinical Study Identifier: NCT03369665

Find a site near you

Start Over

VALEOMED Kft

Esztergom, Hungary
  Connect »